C₂₃H₂₇FN₄O₂ (P274)
Quantities
| P4250 | defined daily dose | 2.7 |
| P4250 | defined daily dose | 5 |
| P2067 | mass | 410.211804 |
| P3780 | active ingredient in | ... | Q47522095 (Risperdal) | Risperdal |
| P233 | canonical SMILES | String | CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F | ??? |
| P373 | Commons category | String | Risperidone | ??? |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q650 (fluorine) | fluorine |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q12135 (mental disorder) | mental disorder |
| P2175 | medical condition treated | ... | Q18671 (intermittent explosive disorder) | intermittent explosive disorder |
| P2175 | medical condition treated | ... | Q11081 (Alzheimer's disease) | Alzheimer's disease |
| P2175 | medical condition treated | ... | Q38404 (autism) | autism |
| P2175 | medical condition treated | ... | Q83030 (dementia) | dementia |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q170082 (psychosis) | psychosis |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q188638 (mood disorder) | mood disorder |
| P2175 | medical condition treated | ... | Q183560 (intellectual disability) | intellectual disability |
| P2175 | medical condition treated | ... | Q41112 (schizophrenia) | schizophrenia |
| P2175 | medical condition treated | ... | Q178190 (obsessive-compulsive disorder) | obsessive-compulsive disorder |
| P2175 | medical condition treated | ... | Q191779 (Tourette syndrome) | Tourette syndrome |
| P2175 | medical condition treated | ... | Q270673 (personality disorder) | personality disorder |
| P2175 | medical condition treated | ... | Q202387 (post-traumatic stress disorder) | post-traumatic stress disorder |
| P2175 | medical condition treated | ... | Q1328833 (oppositional defiant disorder) | oppositional defiant disorder |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q544006 (anxiety disorder) | anxiety disorder |
| P2175 | medical condition treated | ... | Q596474 (conduct disorder) | conduct disorder |
| P2175 | medical condition treated | ... | Q834047 (schizoaffective disorder) | schizoaffective disorder |
| P2175 | medical condition treated | ... | Q1201835 (impulse control disorder) | impulse control disorder |
| P2175 | medical condition treated | ... | Q4915474 (bipolar I disorder) | bipolar I disorder |
| P2175 | medical condition treated | ... | Q6691991 (pervasive developmental disorder) | pervasive developmental disorder |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P361 | part of | ... | Q22274452 (response to risperidone) | response to risperidone |
| P129 | physically interacts with | ... | Q288797 (5-hydroxytryptamine receptor 1B) | 5-hydroxytryptamine receptor 1B |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P129 | physically interacts with | ... | Q21108118 (5-hydroxytryptamine receptor 2C) | 5-hydroxytryptamine receptor 2C |
| P129 | physically interacts with | ... | Q21109355 (5-hydroxytryptamine receptor 7) | 5-hydroxytryptamine receptor 7 |
| P129 | physically interacts with | ... | Q21109363 (5-hydroxytryptamine receptor 6) | 5-hydroxytryptamine receptor 6 |
| P129 | physically interacts with | ... | Q21110872 (Dopamine receptor D3) | Dopamine receptor D3 |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q4734884 (Adrenoceptor alpha 1A) | Adrenoceptor alpha 1A |
| P129 | physically interacts with | ... | Q4734886 (Adrenoceptor alpha 1B) | Adrenoceptor alpha 1B |
| P129 | physically interacts with | ... | Q4734887 (Adrenoceptor alpha 1D) | Adrenoceptor alpha 1D |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P129 | physically interacts with | ... | Q21115051 (5-hydroxytryptamine receptor 1E) | 5-hydroxytryptamine receptor 1E |
| P129 | physically interacts with | ... | Q21115052 (5-hydroxytryptamine receptor 1F) | 5-hydroxytryptamine receptor 1F |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q300989 (levodopa) | levodopa |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q411188 (aripiprazole) | aripiprazole |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q413050 (tetrabenazine) | tetrabenazine |
| P769 | significant drug interaction | ... | Q413581 (bromocriptine) | bromocriptine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q420590 (ropinirol) | ropinirol |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P9989 | stylized name | String | RisperDAL | ??? |
| P9989 | stylized name | String | risperiDONE | ??? |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q208144 (antipsychotics) | antipsychotics |
| P2868 | subject has role | ... | Q1328275 (H1 antagonist) | H1 antagonist |
| P2868 | subject has role | ... | Q758295 (atypical antipsychotic) | atypical antipsychotic |
| P2868 | subject has role | ... | Q1927838 (alpha blocker) | alpha blocker |
| P2868 | subject has role | ... | Q7455047 (serotonin antagonist) | serotonin antagonist |
| P2868 | subject has role | ... | Q3271533 (dopamine antagonist) | dopamine antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | risperidone | ??? |
Why not click here or view trends?
log id: 3798803